Cargando…

miR-708–3p promotes gastric cancer progression through downregulating ETNK1

MicroRNAs (miRNAs) are small, evolutionarily conserved, non-coding RNAs playing a role in the proliferation, metastasis, apoptosis, chemo-sensitivity, and chemo-resistance of gastric cancer, as well as the stemness of gastric cancer stem cells. miR-708–3p induces gastric cancer cell chemo-resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Jincai, Wang, Qingdong, Wang, Jingren, Xu, Bo, Liu, Shuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558739/
https://www.ncbi.nlm.nih.gov/pubmed/37809692
http://dx.doi.org/10.1016/j.heliyon.2023.e19544
_version_ 1785117345264435200
author Shang, Jincai
Wang, Qingdong
Wang, Jingren
Xu, Bo
Liu, Shuang
author_facet Shang, Jincai
Wang, Qingdong
Wang, Jingren
Xu, Bo
Liu, Shuang
author_sort Shang, Jincai
collection PubMed
description MicroRNAs (miRNAs) are small, evolutionarily conserved, non-coding RNAs playing a role in the proliferation, metastasis, apoptosis, chemo-sensitivity, and chemo-resistance of gastric cancer, as well as the stemness of gastric cancer stem cells. miR-708–3p induces gastric cancer cell chemo-resistance, but its actual role in gastric cancer progression remains unclear. This paper shows that miR-708–3p is upregulated in gastric cancer samples and that a high miR-708–3p expression in gastric cancer patients is associated with poor overall survival. Our functional study results indicate that miR-708–3p overexpression promotes gastric cancer cell proliferation and migration, inhibits cell apoptosis, and facilitates the transition from the G0/G1 to the G2/M phase. Furthermore, reducing miR-708–3p levels yielded opposite effects. Next, our in vivo experiments revealed that miR-708–3p advanced gastric cancer cell growth in nude mice. The underlying mechanism was the regulation of ethanolamine kinase 1 (ETNK1) expression by miR-708–3p, which bound to the 3′UTR of the ETNK1 gene in gastric cancer cells. Finally, the recovery assay results showed that ETNK1 overexpression could slow miR-708-3p-induced gastric cancer progression. In conclusion, we identified a new miR-708–3p/ETNK1 pathway involved in gastric cancer progression. These results may offer new targets for gastric cancer therapy and markers for gastric cancer prognosis.
format Online
Article
Text
id pubmed-10558739
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105587392023-10-08 miR-708–3p promotes gastric cancer progression through downregulating ETNK1 Shang, Jincai Wang, Qingdong Wang, Jingren Xu, Bo Liu, Shuang Heliyon Research Article MicroRNAs (miRNAs) are small, evolutionarily conserved, non-coding RNAs playing a role in the proliferation, metastasis, apoptosis, chemo-sensitivity, and chemo-resistance of gastric cancer, as well as the stemness of gastric cancer stem cells. miR-708–3p induces gastric cancer cell chemo-resistance, but its actual role in gastric cancer progression remains unclear. This paper shows that miR-708–3p is upregulated in gastric cancer samples and that a high miR-708–3p expression in gastric cancer patients is associated with poor overall survival. Our functional study results indicate that miR-708–3p overexpression promotes gastric cancer cell proliferation and migration, inhibits cell apoptosis, and facilitates the transition from the G0/G1 to the G2/M phase. Furthermore, reducing miR-708–3p levels yielded opposite effects. Next, our in vivo experiments revealed that miR-708–3p advanced gastric cancer cell growth in nude mice. The underlying mechanism was the regulation of ethanolamine kinase 1 (ETNK1) expression by miR-708–3p, which bound to the 3′UTR of the ETNK1 gene in gastric cancer cells. Finally, the recovery assay results showed that ETNK1 overexpression could slow miR-708-3p-induced gastric cancer progression. In conclusion, we identified a new miR-708–3p/ETNK1 pathway involved in gastric cancer progression. These results may offer new targets for gastric cancer therapy and markers for gastric cancer prognosis. Elsevier 2023-08-28 /pmc/articles/PMC10558739/ /pubmed/37809692 http://dx.doi.org/10.1016/j.heliyon.2023.e19544 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
Shang, Jincai
Wang, Qingdong
Wang, Jingren
Xu, Bo
Liu, Shuang
miR-708–3p promotes gastric cancer progression through downregulating ETNK1
title miR-708–3p promotes gastric cancer progression through downregulating ETNK1
title_full miR-708–3p promotes gastric cancer progression through downregulating ETNK1
title_fullStr miR-708–3p promotes gastric cancer progression through downregulating ETNK1
title_full_unstemmed miR-708–3p promotes gastric cancer progression through downregulating ETNK1
title_short miR-708–3p promotes gastric cancer progression through downregulating ETNK1
title_sort mir-708–3p promotes gastric cancer progression through downregulating etnk1
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558739/
https://www.ncbi.nlm.nih.gov/pubmed/37809692
http://dx.doi.org/10.1016/j.heliyon.2023.e19544
work_keys_str_mv AT shangjincai mir7083ppromotesgastriccancerprogressionthroughdownregulatingetnk1
AT wangqingdong mir7083ppromotesgastriccancerprogressionthroughdownregulatingetnk1
AT wangjingren mir7083ppromotesgastriccancerprogressionthroughdownregulatingetnk1
AT xubo mir7083ppromotesgastriccancerprogressionthroughdownregulatingetnk1
AT liushuang mir7083ppromotesgastriccancerprogressionthroughdownregulatingetnk1